| Disease |
MiRNA expression |
Reference |
| Cancer |
|
|
| B-CLL |
miR-15, miR-16 |
51
|
| Breast cancer |
miR-125b, miR-145, miR-21, miR-155, miR-210 |
22,26,27
|
| Lung |
miR-155, let-7a, |
27
|
| Gastric cancer |
miR-145 |
52
|
| Liver cancer |
miR-29b |
53
|
| Infectious diseases |
|
|
| HCV |
miR-122, miR-155 |
15,54
|
| HIV-1 |
miR-28, miR-125b, miR-150, miR-223, miR-382 |
55
|
| Influenza virus |
miR-21, miR-223 |
56
|
| Immune mediated pathology |
|
|
| Multiple sclerosis |
miR-145, miR-34a, miR-155, miR-326 |
57
|
| Systemic lupus erythematosus |
miR-146a |
58
|
| Type II diabetes |
miR-144, miR-146a, miR-150, miR-182, miR-103, miR-107 |
59
|
| Nonalcoholic fatty liver disease |
miR-200a, miR-200b, miR-429, miR-122, miR-451, miR-27 |
60
|
| Non-alcoholic steatohepatitis |
miR-29c, miR-34a, miR-155, miR-200b |
61
|
| Neurodegenerative diseases |
|
|
| Parkinson’s disease |
miR-30b, miR-30c, miR-26a, miR-133b, miR-184*, let-7 |
62
|
| Alzheimer’s disease |
miR-29b-1, miR-29a, miR-9 |
63
|